Rail Car Collision System
    41.
    发明申请
    Rail Car Collision System 有权
    轨道车碰撞系统

    公开(公告)号:US20100199881A1

    公开(公告)日:2010-08-12

    申请号:US12704263

    申请日:2010-02-11

    CPC classification number: B61D15/06 B61D17/06 Y10T29/49826

    Abstract: A rail car collision system is disclosed that includes a front face and an underframe having a first anticlimber. The first anticlimber protrudes from and extends across at least a portion of the front face at a first position. At least one second anticlimber extends along at least a portion of the front face at a second position that is vertically different than the first position.

    Abstract translation: 公开了一种轨道车辆碰撞系统,其包括前表面和具有第一防结构的底架。 第一防弹件在第一位置处突出并延伸穿过前表面的至少一部分。 在与第一位置垂直不同的第二位置处,至少一个第二防弹件沿前表面的至少一部分延伸。

    Rail car collision system
    42.
    发明授权
    Rail car collision system 有权
    轨道车碰撞系统

    公开(公告)号:US07690314B2

    公开(公告)日:2010-04-06

    申请号:US11786813

    申请日:2007-04-12

    CPC classification number: B61D15/06 B61D17/06 Y10T29/49826

    Abstract: A rail car collision system is disclosed that includes a front face and an underframe having a first anticlimber. The first anticlimber protrudes from and extends across at least a portion of the front face at a first position. At least one second anticlimber extends along at least a portion of the front face at a second position that is vertically different than the first position.

    Abstract translation: 公开了一种轨道车辆碰撞系统,其包括前表面和具有第一防结构的底架。 第一防弹件在第一位置处突出并延伸穿过前表面的至少一部分。 在与第一位置垂直不同的第二位置处,至少一个第二防弹件沿前表面的至少一部分延伸。

    Indole derivatives
    48.
    发明授权
    Indole derivatives 失效
    吲哚衍生物

    公开(公告)号:US4833153A

    公开(公告)日:1989-05-23

    申请号:US928037

    申请日:1986-11-07

    CPC classification number: C07D403/06 C07D209/16

    Abstract: Compounds are disclosed of formula (I): ##STR1## wherein one of R.sup.1, R.sup.2 and R.sup.3 represents hydrogen, C.sub.1-6 alkyl C.sub.3-6 alkenyl, hydroxy, C.sub.1-4 alkoxy or a C.sub.2-5 alkoxycarbonyl group, a phenyl or substituted phenyl group or a phen(C.sub.1-4)alkyl or substituted phen(C.sub.1-4)alkyl group; and the other two each independently represents hydrogen, C.sub.1-6 alkyl, or R.sup.2 and R.sup.3 together form an alkylene chain --(CH.sub.2).sub.n --where n is 2 or 3, bridging the nitrogen atoms to which they are attached; R.sup.4 and R.sup.5, each independently represents hydrogen, C.sub.1-3 alkyl or propenyl; R.sup.6 represents hydrogen, C.sub.1-3 alkyl, and the physiologically acceptable salts and solvates thereof.The compounds (I) have potent and selective vasoconstrictor activity and are potentially useful for the treatment of migraine. The compounds (I) may be formulated in conventional manner as pharmaceutical compositions for administration by any convenient route.

    Abstract translation: 公开了式(I)的化合物:其中R 1,R 2和R 3中的一个表示氢,C 1-6烷基C 3-6烯基,羟基,C 1-4烷氧基或C 2-5烷氧基羰基, 苯基或取代的苯基或苯基(C 1-4)烷基或取代的苯基(C 1-4)烷基; 而另外两个独立地表示氢,C 1-6烷基或R 2和R 3一起形成亚烷基链 - (CH 2)n - ,其中n为2或3,桥接与它们相连的氮原子; R 4和R 5各自独立地表示氢,C 1-3烷基或丙烯基; R6代表氢,C1-3烷基及其生理上可接受的盐和溶剂合物。 化合物(I)具有有效和选择性的血管收缩剂活性,并且可用于治疗偏头痛。 化合物(I)可以以常规方式配制为用于通过任何方便途径给药的药物组合物。

Patent Agency Ranking